Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$50.35
-2.1%
$53.13
$43.38
$62.88
$6.82B1.081.12 million shs613,282 shs
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$28.41
-3.3%
$35.67
$27.18
$56.41
$2.23B1.12705,624 shs1.58 million shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$94.53
-2.3%
$102.07
$78.28
$212.43
$2.30B0.69252,730 shs147,160 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$73.38
-0.9%
$74.76
$62.58
$85.62
$4.26B0.89491,397 shs341,471 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$35.56
+1.3%
$30.51
$13.82
$40.74
$2.30B1.121.73 million shs1.57 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
+0.31%+0.51%+0.57%-4.28%-10.77%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.00%-8.02%-12.04%-29.70%-50.07%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-1.06%+0.88%-1.44%+1.00%-46.34%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
-0.20%+3.52%+1.70%-5.37%-5.22%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+0.43%+10.61%+16.68%+52.76%-3.33%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.8579 of 5 stars
3.32.00.04.12.74.23.1
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
4.8092 of 5 stars
3.13.00.04.03.01.73.8
ICU Medical, Inc. stock logo
ICUI
ICU Medical
4.3083 of 5 stars
3.51.00.03.92.52.51.9
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
4.8772 of 5 stars
4.42.00.03.82.92.52.5
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
3.1742 of 5 stars
2.22.00.04.93.50.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.67
Moderate Buy$66.3331.74% Upside
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
2.22
Hold$44.8958.00% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$123.0030.12% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.89
Moderate Buy$92.5026.06% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.45
Hold$39.4510.95% Upside

Current Analyst Ratings

Latest IART, GMED, ICUI, TNDM, and MMSI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$34.00 ➝ $45.00
4/23/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$37.00 ➝ $40.00
4/16/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$98.00
4/11/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$88.00
4/11/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$88.00
4/3/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$38.00
4/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$31.00 ➝ $38.00
3/26/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00 ➝ $37.00
3/18/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00
3/15/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$25.00 ➝ $31.00
3/1/2024
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$46.00 ➝ $41.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.02B6.68$3.54 per share14.21$29.32 per share1.72
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$1.54B1.45$4.67 per share6.09$20.31 per share1.40
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.26B1.02$14.82 per share6.38$87.96 per share1.07
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.26B3.39$4.77 per share15.37$20.81 per share3.53
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$747.72M3.07N/AN/A$4.81 per share7.39

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.1743.0315.351.517.83%8.82%7.20%5/7/2024 (Confirmed)
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$67.74M$0.8334.237.870.884.39%15.19%6.59%5/6/2024 (Confirmed)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$1.23N/A17.57N/A-1.31%6.35%3.03%5/7/2024 (Confirmed)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$94.41M$1.6245.3020.052.077.51%14.63%9.19%4/30/2024 (Confirmed)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$3.44N/AN/AN/A-29.77%-31.48%-10.75%5/2/2024 (Confirmed)

Latest IART, GMED, ICUI, TNDM, and MMSI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.55N/A-$0.55N/AN/AN/A  
5/7/2024N/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.8350N/A-$0.8350N/AN/AN/A  
5/6/2024N/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.55N/A-$0.55N/AN/AN/A  
5/2/2024N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.80N/A+$0.80N/AN/AN/A  
4/30/2024N/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.70N/A-$0.70N/AN/AN/A  
2/28/202412/31/2023
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
$0.90$0.89-$0.01$1.53$399.30 million$397.00 million    
2/28/2024Q4 2023
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.77$0.81+$0.04$1.15$320.66 million$324.52 million    
2/27/2024Q4 2023
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.85$1.24+$0.39$3.19$564.77 million$587.86 million
2/21/2024Q4 2023
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.23-$0.27-$0.04-$0.08$204.86 million$196.80 million
2/20/2024Q4 2023
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.10
4.88
2.72
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
0.94
3.45
2.18
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.74
2.53
1.06
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.68
5.45
3.95
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.91
3.83
3.02

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
84.78%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million102.48 millionOptionable
Integra LifeSciences Holdings Co. stock logo
IART
Integra LifeSciences
3,94678.60 million76.17 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,00024.36 million22.73 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
6,95058.06 million55.92 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,40064.56 million62.95 millionOptionable

IART, GMED, ICUI, TNDM, and MMSI Headlines

SourceHeadline
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to DeclineEarnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
zacks.com - April 25 at 11:05 AM
Jennison Associates LLC Has $38.18 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Jennison Associates LLC Has $38.18 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
marketbeat.com - April 25 at 7:19 AM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded to "Outperform" by SVB LeerinkTandem Diabetes Care (NASDAQ:TNDM) Upgraded to "Outperform" by SVB Leerink
marketbeat.com - April 25 at 7:11 AM
Tandem Diabetes Care (TNDM) to Release Earnings on ThursdayTandem Diabetes Care (TNDM) to Release Earnings on Thursday
americanbankingnews.com - April 25 at 2:14 AM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $40.00 at Stifel NicolausTandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $40.00 at Stifel Nicolaus
americanbankingnews.com - April 24 at 4:02 AM
Tandem Diabetes Care IncTandem Diabetes Care Inc
morningstar.com - April 23 at 10:56 PM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel NicolausTandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel Nicolaus
marketbeat.com - April 23 at 1:49 PM
Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%
marketbeat.com - April 23 at 1:25 PM
Contrasting Tandem Diabetes Care (NASDAQ:TNDM) & IceCure Medical (NASDAQ:ICCM)Contrasting Tandem Diabetes Care (NASDAQ:TNDM) & IceCure Medical (NASDAQ:ICCM)
americanbankingnews.com - April 20 at 2:04 AM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at StockNews.comTandem Diabetes Care (NASDAQ:TNDM) Upgraded at StockNews.com
americanbankingnews.com - April 19 at 2:14 AM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.
marketbeat.com - April 17 at 4:44 AM
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%
marketbeat.com - April 15 at 1:55 PM
Raymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Raymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
marketbeat.com - April 15 at 4:26 AM
Validea Detailed Fundamental Analysis - TNDMValidea Detailed Fundamental Analysis - TNDM
nasdaq.com - April 14 at 11:34 AM
Tandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to SellTandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to Sell
marketbeat.com - April 11 at 11:12 PM
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
businesswire.com - April 9 at 4:05 PM
Whats Driving Tandem Diabetes Care Incs Surprising 25% Stock Rally?What's Driving Tandem Diabetes Care Inc's Surprising 25% Stock Rally?
gurufocus.com - April 9 at 12:02 PM
Bullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of StockBullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of Stock
finance.yahoo.com - April 9 at 8:55 AM
1 Beaten-Down Stock That Could Make You Richer1 Beaten-Down Stock That Could Make You Richer
fool.com - April 7 at 12:07 PM
Should You Invest in Tandem Diabetes Care (TNDM)?Should You Invest in Tandem Diabetes Care (TNDM)?
finance.yahoo.com - April 5 at 9:49 AM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00
marketbeat.com - April 3 at 3:22 PM
Tandem Mobi automated insulin pump wins FDA nod for expanded pediatric useTandem Mobi automated insulin pump wins FDA nod for expanded pediatric use
drugdeliverybusiness.com - April 2 at 2:43 PM
Chicago Capital LLC Has $14.11 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Chicago Capital LLC Has $14.11 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
marketbeat.com - April 2 at 6:37 AM
Tandem Diabetes Care (NASDAQ:TNDM)  Shares Down 6.1% Tandem Diabetes Care (NASDAQ:TNDM) Shares Down 6.1%
marketbeat.com - April 1 at 3:48 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Integra LifeSciences logo

Integra LifeSciences

NASDAQ:IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
ICU Medical logo

ICU Medical

NASDAQ:ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Merit Medical Systems logo

Merit Medical Systems

NASDAQ:MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Tandem Diabetes Care logo

Tandem Diabetes Care

NASDAQ:TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.